| 國立臺灣大學 |
2006 |
Antiviral effects of saikosaponins on human coronavirus 229E in vitro
|
Cheng, P. W.; Ng, L.T.; Chiang, L. C.; Lin, C. C. |
| 亞洲大學 |
2019-10 |
Antiviral efficacy of bromo-anilino substituents of 4,5-dihydrofuran-3-carboxylate compound CW-33 against Japanese encephalitis virus
|
JC, Lien;JC, Lien;黃素華;Huang, Su-Hua;林振文 |
| 國立成功大學 |
2021-04-1 |
Antiviral Efficacy of the Anesthetic Propofol against Dengue Virus Infection and Cellular Inflammation
|
Shen;Ting-Jing;Chen;Chia-Ling;Jhan;Ming-Kai;Tseng;Po-Chun;Satria;Dani, Rahmat;Hsing;Chung-Hsi;Lin;Chiou-Feng |
| 國立中山大學 |
1990-11-17 |
Antiviral furoquinoline alkaloids from Melicope triphylla
|
S.K. Wang;C.Y. Duh; R.S. Hou; Y.C. Wu; S.T. Lu; S.F. Chang |
| 國立成功大學 |
2021 |
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
|
Pan, C.Q.;Chang, T.-T.;Bae, S.H.;Brunetto, M.;Seto, W.-K.;Coffin, Coffin C.S.;Tan, S.K.;Mo, S.;Flaherty, J.F.;Gaggar, A.;Nguyen, M.H.;Celen, M.K.;Thompson, A.;Gane, E.J. |
| 國立臺灣大學 |
2010-03 |
Antiviral mechanism of Barramundi Mx against betanodavirus involves the inhibition of viral RNA synthesis through the interference of viral RdRp.
|
Wu, Yu-Chi; Lu, Yi-Fan; Chi, Shau-Chi |
| 臺北醫學大學 |
2014 |
Antiviral Natural Products and Herbal Medicines
|
LT*, Lin;WC, Hsu;CC*, Lin |
| 臺北醫學大學 |
2014 |
Antiviral Natural Products and Herbal Medicines
|
LT*, Lin;Hsu, WC;CC*, Lin |
| 國立臺灣科技大學 |
2020 |
Antiviral pneumonia to treat influenza virus
|
Mazraedoost, S.;Mousavi, S.M.;Hashemi, S.A.;Gholami, A. |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via inhibition of viral 2A protease
|
Ching-Ying W Ching-Ying Wang ；An-Cheng Hua An-Cheng Huang ；Mann-Jen Hou Mann-Jen Hour ；黃素華 Su-Hua Huang ；Szu-Hao Kung Szu-Hao Kung ；Chao-Hsien C Chao-Hsien Chen ；I-Chieh Chen I-Chieh Chen ；Yuan-Shiun Yuan-Shiun Chang ；Jin-Cherng L Jin-Cherng Lien ；林振文 |
| 亞洲大學 |
201506 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via inhibition of viral 2A protease
|
Anonymous |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via inhibition of viral 2A protease
|
Ching-Ying, W;Wang, Ching-Ying;Hua, An-Cheng;Huang, An-Cheng;Hou, Mann-Jen;Hour, Mann-Jen;黃素華;Huang, Su-Hua;Kung, Szu-Hao;Kung, Szu-Hao;Chao-Hsien, C;Chen, Chao-Hsien;Chen, I-Chieh;Chen, I-Chieh;Yuan-Shiun;Chang, Yuan-Shiun;Jin-Cherng, L;Lien, Jin-Cherng;林振文 |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via inhibition of viral 2A protease
|
Lien；林振文, Ching-Ying W；Ching-Ying Wang；An-Cheng Hua；An-Cheng Huang；Mann-Jen Hou；Mann-Jen Hour；黃素華；Su-Hua Huang；Szu-Hao Kung；Szu-Hao Kung；Chao-Hsien C；Chao-Hsien Chen；I-Chieh Chen；I-Chieh Chen；Yuan-Shiun；Yuan-Shiun Chang；Jin-Cherng L；Jin-Cherng |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease
|
Lien；林振文*, Ching-Ying W；Ching-Ying Wang；An-Cheng Hua；An-Cheng Huang；Mann-Jen Hou；Mann-Jen Hour；黃素華；Su-Hua Huang；Szu-Hao Kung；Szu-Hao Kung；Chao-Hsien C；Chao-Hsien Chen；I-Chieh Chen；I-Chieh Chen；Yuan-Shiun C；Yuan-Shiun Chang；Jin-Cherng L；Jin-Cherng |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease
|
Lien；林振文, Ching-Ying W；Ching-Ying Wang；An-Cheng Hua；An-Cheng Huang；Mann-Jen Hou；Mann-Jen Hour；黃素華；Su-Hua Huang；Szu-Hao Kung；Szu-Hao Kung；Chao-Hsien C；Chao-Hsien Chen；I-Chieh Chen；I-Chieh Chen；Yuan-Shiun C；Yuan-Shiun Chang；Jin-Cherng L；Jin-Cherng |
| 亞洲大學 |
2015-06 |
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via inhibition of viral 2A protease
|
Wang), Ching-Ying W(Ching-Ying;Huang), An-Cheng Hua(An-Cheng;Hour), Mann-Jen Hou(Mann-Jen;Huang), 黃素華(Su-Hua;Kung), Szu-Hao Kung(Szu-Hao;Chen), Chao-Hsien C(Chao-Hsien;Chen), I-Chieh Chen(I-Chieh;Chang), Yuan-Shiun(Yuan-Shiun;Lien), Jin-Cherng L(Jin-Cherng;林振文 |
| 中國醫藥大學 |
2015-06 |
Antiviral potential of a novel compound CW-33 against Enterovirus A71 via inhibition viral 2A protease
|
(Ching-Ying Wang);(An-Cheng Huang);侯曼貞(Hour Mann-Jen);(Su-Hua Huang);(Szu-Hao Kung);陳昭賢(Chao-Hsien Chen);(I-Chieh Chen);張永勳(Yuan Shiun Chang);連金城(Lien Jin Cherng)*;林振文(Lin Cheng Wen)* |
| 臺大學術典藏 |
2020-12-23T03:35:03Z |
Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study
|
Huang H.-H.; FEI-YUAN HSIAO; Chen H.-M.; Wang C.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-07-06T01:26:14Z |
Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study
|
Huang H.-H.; FEI-YUAN HSIAO; Chen H.-M.; Wang C.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2022-09-19T03:16:36Z |
Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study
|
Huang H.-H.; FEI-YUAN HSIAO; Chen H.-M.; Wang C.-Y.; Ko B.-S. |
| 國立成功大學 |
2011 |
ANTIVIRAL PROTEIN MX MODULATES INTRACELLULAR LOCALIZATION OF NODAVIRUS COAT PROTEIN IN GROUPER
|
Chen, Young-Mao; Shie, Pei-shiuan; Lin, Wei-Cheng; Chen, Tzong-Yueh |
| 嘉南藥理大學 |
2009 |
Antiviral Research
|
Elsevier SDOL |
| 國立臺灣大學 |
1999 |
Antiviral Tannins from Two Phyllanthus Species
|
陳瓊雪; 林美珠; 李水盛; 邱卓凡; CHEN LIU, KARIN CHIUNG-SHEUE ; LIN, MEI-TSU; LEE, SHOEI-SHENG; CHIOU, JWO-FARN |
| 臺大學術典藏 |
2018-09-10T07:43:56Z |
Antiviral tannins from two Phyllanthus species
|
Liu, K.C.S.C.;Lin, M.-T.;Lee, S.-S.;Chiou, J.-F.;Ren, S.;Lien, E.J.; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2021-07-16T06:18:32Z |
Antiviral tannins from two Phyllanthus species
|
Liu K.C.S.C.; Lin M.-T.; SHOEI-SHENG LEE; Chiou J.-F.; Ren S.; Lien E.J. |
| 臺大學術典藏 |
2020-11-03T08:19:40Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:17Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:22Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H; | Tseng T.-C; | Liu C.-J; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:33Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:06Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; CHUN-JEN LIU; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:01Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:11Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
TUNG-HUNG SU; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 國立臺灣大學 |
2013 |
Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence
|
Yeh, Yi-Chun; Chen, Pei-Jer; Lai, Mei-Shu; 賴美淑; 陳培哲 |
| 臺大學術典藏 |
2021-07-03T03:34:17Z |
Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2]
|
Yeh Y.-C.; PEI-JER CHEN; Lai M.-S. |
| 臺大學術典藏 |
2020-03-04T07:45:19Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; CHIN-HSIEN LIN; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:26Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2019 |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.;Yang H.-C.;Tseng T.-C.;Chou S.-W.;Chin-Hsien Lin;Liu C.-H.;Liu C.-J.;Chen C.-L.;Kao J.-H.; Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; CHIN-HSIEN LIN; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:15Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:20Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:45Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:12Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; CHUN-JEN LIU; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:03Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Kao J.-H. |
| 國家衛生研究院 |
2023-09-02 |
Antiviral therapy of coronavirus disease 2019 (COVID-19)
|
Chen, PY;Wang, JT;Chang, SC |
| 臺大學術典藏 |
2020-03-10T03:29:42Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
HUEY-LING CHEN; Ni Y.-H.; Chen P.-J.; Chang M.-H. |
| 臺大學術典藏 |
2020-12-28T08:14:03Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chang M.-H.; Chen P.-J.; YEN-HSUAN NI; Chen H.-L. |
| 臺大學術典藏 |
2021-01-04T07:32:10Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chen H.-L.; Ni Y.-H.; Chen P.-J.; MEI-HWEI CHANG |
| 臺大學術典藏 |
2021-07-03T03:33:30Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chen H.-L.;Ni Y.-H.;Pei-Jer Chen;Chang M.-H.; Chen H.-L.; Ni Y.-H.; PEI-JER CHEN; Chang M.-H. |
| 義守大學 |
2014-04 |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Yao-Chun Hsu;Jaw-Town Lin;Hsiu J. Ho;Yu-Hsi Kao;Yen-Tsung Huang;Nai-Wan Hsiao;Ming-Shiang Wu;Yi-Ya Liu;Chun-Ying Wu |
| 臺大學術典藏 |
2021-02-02T02:21:28Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu Y.-C.; Lin J.-T.; Ho H.J.; Kao Y.-H.; Huang Y.-T.; Hsiao N.-W.; MING-SHIANG WU; Liu Y.-Y.; Wu C.-Y. |
